Loading…
Thursday September 17, 2026 9:55am - 10:25am EDT
Corporate press releases, investor decks, and congress abstracts are carefully crafted to shape market perception. Relying on this curated messaging leaves competitive intelligence and commercial strategy teams reactive, vulnerable, and a step behind. To build true competitive insights, teams must ground their analysis in the primary source: official labels, approval packages, review documents, and regulatory registry updates. 
 
This session explores how to shift from tracking corporate messaging to decoding the unvarnished regulatory record. Attendees will learn how to identify critical divergences between public narratives and official filings, identify early signals that predict market shifts months before public announcements, and establish a repeatable CI cadence that directly elevates brand planning, launch readiness, and market differentiation. 
Speakers
avatar for Sam Kay

Sam Kay

VP Pharma, Basil Systems
Sam Kay leads the pharma vertical at Basil Systems, an AI-powered regulatory intelligence platform used by pharmaceutical companies to build strategy based on the regulatory record. He brings over 14 years in regulatory affairs, including leading Cortellis Regulatory Intelligence... Read More →
Thursday September 17, 2026 9:55am - 10:25am EDT
Junior Ballroom D

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link